SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

6620 (6620) News

Follow 6620 (6620) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 6620 Asset market Sector Markets 90 days 1 Updated Sep 11, 2026, 11:31 AM UTC Open live news feed
M Handa Oncology receives FDA final approval for OMCAZIO cabozantinib FDA granted final approval for OMCAZIO (cabozantinib) capsules, including administration without regard to food and removal of strict fasting requirements for cabozantinib patients. REGULATION | Sep 11, 2026, 11:31 AM UTC